ASCO 2015 round-up: immunotherapy continues to come of age

June 5, 2015 | Alan Worsley,  Science blog, cancer research UK

As you’ll have probably spotted by the array of cancer stories in the media over the last week, the world’s biggest annual cancer conference has just taken place.

The annual American Society of Clinical Oncology (ASCO) meeting brings together over 30,000 oncology professionals from around the world to discuss ...

Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

May 28, 2015 | KENILWORTH, N.J., BUSINESS WIRE

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a New Drug Application to the U.S. ...

Virotherapy: skin cancer successfully treated with herpes-based drug

May 27, 2015 | HANNAH DEVLIN, The guardian

Patients with aggressive skin cancer have been treated successfully using a drug based on the herpes virus, in a trial that could pave the way for a new generation of cancer treatments The findings mark the first positive phase 3 trial results for cancer “virotherapy”, where one disease is harnessed and used to attack another ...

Biomedical research: Diagnosis of Deputies

May 26, 2015 | YOUNES BENNAJAH

The law N° 28-13, introduced in June 2014, was finally adopted by the chamber of deputies. The impact of this new legislation on the development of biomedical research was highlighted by the commetee of social sectors. Members have declared the gap in the law that has long prevailed in this area and has negatively impacted the quality of research shall be filled The final version of the law says : "No clinical biomedical research ...